Insider Trading Alert - IBKR, JNS And ABC Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, Sept. 9, 2014, 75 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $46.83 to $226,304,343.30.

Highlighted Stocks Traded by Insiders:

Interactive Brokers Group (IBKR) - FREE Research Report

Galik Milan, who is SVP Software Development at Interactive Brokers Group, sold 1,800 shares at $23.66 on Sept. 9, 2014. Following this transaction, the SVP Software Development owned 726,617 shares meaning that the stake was reduced by 0.25% with the 1,800-share transaction.

The shares most recently traded at $23.96, up $0.30, or 1.23% since the insider transaction. Historical insider transactions for Interactive Brokers Group go as follows:

  • 4-Week # shares sold: 13,500
  • 12-Week # shares sold: 49,500
  • 24-Week # shares sold: 65,700

The average volume for Interactive Brokers Group has been 351,700 shares per day over the past 30 days. Interactive Brokers Group has a market cap of $1.4 billion and is part of the financial sector and financial services industry. Shares are down 2.05% year-to-date as of the close of trading on Tuesday.

Interactive Brokers Group, Inc. operates as an automated electronic broker and market maker. The stock currently has a dividend yield of 1.67%. The company has a P/E ratio of 24.4. Currently, there are 2 analysts who rate Interactive Brokers Group a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on IBKR - FREE

TheStreet Quant Ratings rates Interactive Brokers Group as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, compelling growth in net income, revenue growth, reasonable valuation levels and expanding profit margins. We feel these strengths outweigh the fact that the company has had generally high debt management risk by most measures that we evaluated. Get the full Interactive Brokers Group Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Janus Capital Group (JNS) - FREE Research Report

Schafer Glenn S, who is Director at Janus Capital Group, sold 1,541 shares at $12.00 on Sept. 9, 2014. Following this transaction, the Director owned 31,079 shares meaning that the stake was reduced by 4.72% with the 1,541-share transaction.

The shares most recently traded at $11.84, down $0.16, or 1.38% since the insider transaction. Historical insider transactions for Janus Capital Group go as follows:

  • 4-Week # shares bought: 5,000
  • 4-Week # shares sold: 41,616
  • 12-Week # shares bought: 5,000
  • 12-Week # shares sold: 41,616
  • 24-Week # shares bought: 5,000
  • 24-Week # shares sold: 41,616

The average volume for Janus Capital Group has been 2.1 million shares per day over the past 30 days. Janus Capital Group has a market cap of $2.3 billion and is part of the financial sector and financial services industry. Shares are down 4.2% year-to-date as of the close of trading on Tuesday.

Janus Capital Group, Inc. is a publicly owned asset management holding company with approximately $167.7 billion in assets under management. It also provides retirement planning, investment planning, tax planning, investment for college, and tax planning services to its clients. The stock currently has a dividend yield of 2.66%. The company has a P/E ratio of 16.5. Currently, there is 1 analyst who rates Janus Capital Group a buy, 2 analysts rate it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on JNS - FREE

TheStreet Quant Ratings rates Janus Capital Group as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance, impressive record of earnings per share growth, compelling growth in net income and reasonable valuation levels. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full Janus Capital Group Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

AmerisourceBergen (ABC) - FREE Research Report

Hagenlocker Edward E, who is Director at AmerisourceBergen, sold 4,852 shares at $78.09 on Sept. 9, 2014. Following this transaction, the Director owned 0 shares meaning that the stake was reduced by 100% with the 4,852-share transaction.

The shares most recently traded at $77.94, down $0.15, or 0.19% since the insider transaction. Historical insider transactions for AmerisourceBergen go as follows:

  • 4-Week # shares sold: 7,681
  • 12-Week # shares sold: 7,681
  • 24-Week # shares sold: 7,681

The average volume for AmerisourceBergen has been 1.3 million shares per day over the past 30 days. AmerisourceBergen has a market cap of $17.6 billion and is part of the services sector and wholesale industry. Shares are up 10.94% year-to-date as of the close of trading on Tuesday.

AmerisourceBergen Corporation sources and distributes pharmaceutical products to healthcare providers, pharmaceutical and biotech manufacturers, and specialty drug patients in the United States and internationally. The stock currently has a dividend yield of 1.2%. The company has a P/E ratio of 68.7. Currently, there are 8 analysts who rate AmerisourceBergen a buy, no analysts rate it a sell, and 6 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on ABC - FREE

TheStreet Quant Ratings rates AmerisourceBergen as a hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth, good cash flow from operations and solid stock price performance. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, generally higher debt management risk and poor profit margins. Get the full AmerisourceBergen Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.
null

If you liked this article you might like

Bitcoin Today: Cryptocurrencies Storm Back Thursday, Bulls Rejoice

Bitcoin Today: Cryptocurrencies Storm Back Thursday, Bulls Rejoice

These Bitcoin Stocks Are Rallying as Cryptos Crater

These Bitcoin Stocks Are Rallying as Cryptos Crater

How to Make Money Off Your Brokerage Account by Doing Nothing

How to Make Money Off Your Brokerage Account by Doing Nothing

Can You Spare $150K for Priceline?

Can You Spare $150K for Priceline?

How Sprint, Sirius XM and Interactive Brokers Could Blast Higher in April

How Sprint, Sirius XM and Interactive Brokers Could Blast Higher in April